e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New treatment of IPF still unknown?
A. Wells (London, United Kingdom)
Source:
ERS Live 2007
Number:
16
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Wells (London, United Kingdom). New treatment of IPF still unknown?. ERS Live 2007
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Bernard Yung - 28.06.2009 22:20
Prof. Wells is as brilliant as ever.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
New treatment approaches for IPF
Source: International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis
Year: 2016
New drugs for severe asthma – what should we target and how?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
New antifibrotic drugs: will interstitial diseases patients still need lung transplantation?
Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Year: 2020
The pathogenesis of IPF: what is the latest paradigm?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019
IPF: a distinct clinical entity?
Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases"
Year: 2017
New aspects of COPD ethiopathogenesis
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Is steroid therapy needed in IPF or not?
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
New mechanisms and targets in COPD
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014
Acute exacerbations of IPF: A neglected threat in IPF ?
Source: ERS webinars 2019 - Acute exacerbations of IPF
Year: 2019
New cystic fibrosis therapy targets
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014
How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013
How common is stepping-down asthma treatment in England?
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Use of alternative therapies in patients with asthma and COPD: is there any difference?
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005
Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Medical therapy of sarcoidosis: who to treat and how?
Source: Annual Congress 2012 - PG8 State-of-the-art management of sarcoidosis
Year: 2012
New definition of pulmonary rehabilitation
Source: Annual Congress 2012 - The updated ATS/ERS statement on pulmonary rehabilitation - update from the ATS/ERS Task Force
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept